Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
Launched by STANFORD UNIVERSITY · Feb 14, 2025
Trial Information
Current as of June 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special diet, designed for Asian Americans with type 2 diabetes, affects blood sugar levels. The researchers want to see if meals that reflect cultural preferences can help manage diabetes better, while still following general guidelines for healthy eating. To do this, participants will wear a Continuous Glucose Monitor (CGM) for one month. This device will track their blood sugar levels as they eat both their regular meals and the culturally tailored meals.
To join the study, you need to identify as Asian Indian or Filipino and have been diagnosed with type 2 diabetes. You should also be able to pick up meals from a specific location on the Stanford campus and be willing to wear the CGM for 30 days. However, if you are currently taking certain diabetes medications like insulin or have severe food allergies, you won't be eligible. This trial is not yet recruiting participants, but it aims to provide valuable insights into how personalized diets can improve health for people with diabetes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-identification as Asian Indian or Filipino
- • Diagnosed with T2DM
- • Can pick up meals from a designated area on the Stanford Campus
- • Willing to wear a CGM for 30 days
- Exclusion Criteria:
- • Currently taking insulin, GLP -1 and SGLT 2
- • Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat
- • Those who, in the opinion of the investigators, cannot reliably complete the study protocol.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Minal Moharir, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported